Gray mold caused by Botrytis cinerea is a devastating postharvest disease of kiwifruit. Although 24-Epibrassinolide (EBR) has shown promise in enhancing disease resistance, its metabolic mechanisms in kiwifruit remain unclear. Here, we employed an integrated physiological and metabolomic approach to investigate EBR-induced resistance against B. cinerea in postharvest kiwifruit. EBR treatment significantly reduced lesion development compared to controls. Metabolomic profiling at 24, 48, and 72 h identified 35, 64, and 57 differentially accumulated metabolites, respectively. KEGG pathway enrichment revealed four core pathways: phenylpropanoid/flavonoid biosynthesis, amino acid metabolism, purine/cytokinin signaling, and cuticular/lipid metabolism. Temporal analysis uncovered a triphasic metabolic trajectory: early chemical defense priming (24 h), mid-stage defense amplification with signaling activation (48 h), and late-stage metabolic recovery (72 h). These findings indicate that EBR treatment is associated with time-dependent changes in defense-related metabolites and physiological responses in kiwifruit during B. cinerea infection, suggesting a potential coordinated defense response involving chemical and physical barriers, signaling, and metabolic reallocation. This study provides a comprehensive metabolomic framework for understanding EBR-mediated resistance and offers potential candidate metabolites for postharvest disease management in kiwifruit.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: